Introduction Executive Summary Spinal Cord Injury: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Spinal Cord Injury – DelveInsight’s Analytical Perspective Late Stage Products (Phase III) • Comparative Analysis ES 135: Eusol Biotech • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis MT-3921: Mitsubishi Tanabe Pharma Corporation • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis NVG 291: NervGen Pharma • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical/Discovery Stage Products • Comparative Analysis KAND-567: Kancera • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Spinal Cord Injury Key Companies Spinal Cord Injury Key Products Spinal Cord Injury- Unmet Needs Spinal Cord Injury- Market Drivers and Barriers Spinal Cord Injury- Future Perspectives and Conclusion Spinal Cord Injury Analyst Views Appendix

Table 1 Total Products for Spinal Cord Injury Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Kringle Pharma • Eusol Biotech • Pharmicell • Pharmazz • AbbVie • Acorda Therapeutics • Geron Corporation • ReNetX Bio • GNT Pharma • AlaMab Therapeutics • Mitsubishi Tanabe Pharma • Kancera • Olatec Therapeutics • Scholar Rock • AXONIS Therapeutics • K-STEMCELL • Nordic Life Science Pipeline • NervGen Pharma • Athersys • Healios • Angiocrine Bioscience